Plunkett Research Online: biOasis Technologies, Inc.

BIOASIS TECHNOLOGIES, INC. (BTI:TSX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

biOasis Technologies, Inc. is engaged in the development and commercialization of diagnostics and therapeutic delivery systems related to neurological diseases......



biOasis Technologies, Inc.
Ticker: BTI
Exchange: TSX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 778 383-3280
Fax: 604 215-0091
Address: 10691 Shellbridge Way
Suite 130
Richmond, BC V6X 2W8 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Ronald Erickson
Mark DayCEO/Director/President
See More
biOasis Technologies, Inc. is engaged in the development and commercialization of diagnostics and therapeutic delivery systems related to neurological diseases......See More See More

Auditor: Lancaster & David
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: